nasdaq

LINE Investors Have Opportunity to Lead Lineage, Inc. Securities Fraud Lawsuit with the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--$LINE--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit…

1 month ago

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 16:55 ET  | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British Columbia and BOSTON, Aug. 01, 2025 (GLOBE NEWSWIRE)…

1 month ago

RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action…

1 month ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 01, 2025 17:06 ET  | Source: Taysha Gene Therapies, Inc. DALLAS, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Taysha Gene…

1 month ago

LINEAGE INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Lineage, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead the Lineage Class Action Lawsuit LINE

SAN DIEGO--(BUSINESS WIRE)--Robbins Geller Rudman & Dowd LLP announces that purchasers of Lineage, Inc. (NASDAQ: LINE) common stock in or…

1 month ago

DXP Enterprises, Inc. Announces Second Quarter 2025 Earnings Release and Conference Call

HOUSTON--(BUSINESS WIRE)--#dxpe--DXP Enterprises, Inc. (the “Company”) (NASDAQ: DXPE), a leading business to business products and service distributor that adds value…

1 month ago

Aurora Mobile and Figma: Unleashing Design to Drive Innovation

July 31, 2025 05:00 ET  | Source: Aurora Mobile Limited SHENZHEN, China, July 31, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile…

1 month ago

EXL and Genesys collaborate to transform customer experiences with AI-driven insights and intelligent orchestration

EXL is a premium Genesys AppFoundry partner, bringing advanced data, AI, and domain expertise to the experience orchestration engine July…

1 month ago

FDA Approves Apellis EMPAVELI (pegcetacoplan) as the First C3G and Primary IC-MPGN Treatment for Patients 12 and Older

Proven efficacy across all three key markers of disease—68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of…

1 month ago

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Company Has Received Over 10,000 Paid Pre-Orders for the FX Super One MPV as It Marks the 4th Anniversary of FFAIs Public Listing

Faraday Future Hosts Successful Capitol Hill Club Reception in Washington D.C. on July 23 Showcasing Commitment to American Manufacturing and…

1 month ago